Providing market intelligence for more than 35 years

In The News

New Report Shows Other SVOD Services Creeping Up on Netflix

The report also found that U.S. consumers pay an average of $29 per month for what Parks calls “incremental video-related entertainment beyond pay TV,” and the the biggest chunks of that are movie tickets ($9.32 a month) and SVOD services ($7.95 a month), which will almost certainly rise in 2017 with Netflix’s $2-a-month price increase and the growth of newer streaming services.

“The average spending on subscription OTT video has increased over the past four years, with a notable jump in 2016,” Parks researcher Glenn Hower wrote. “The average monthly spend of $7.95 on subscription OTT video services is remarkably close to the $7.99 pricing of the lowest tiers of service for Netflix and Hulu, indicating that consumer expectations for U.S. market pricing has been set by Hulu and Netflix.”

From the article "New Report Shows Other SVOD Services Creeping Up on Netflix" by Scott Porch.

Previously In The News

Cord-Cutting On The Rise In The US

“Pay TV subscriptions have dropped each year since 2014, falling to 81% of US broadband households in Q3 2016,” said Brett Sappington, senior director of research, Parks Associates. “Several factor...

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

59% of broadband-enabled UK households now access video content online

The proportion of UK households with broadband connections utilising the service to access online video content has reached 59%, according to new research. Parks Associates relayed their key findin...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...